MCID: LVR002
MIFTS: 44

Liver Angiosarcoma malady

Categories: Rare diseases, Cancer diseases, Gastrointestinal diseases, Liver diseases

Aliases & Classifications for Liver Angiosarcoma

About this section

Aliases & Descriptions for Liver Angiosarcoma:

Name: Liver Angiosarcoma 11 13
Angiosarcoma of Liver 11 66
 
Hemangiosarcoma of the Liver 11
Angiosarcoma of the Liver 46

Classifications:



External Ids:

Disease Ontology11 DOID:268
ICD1028 C22.3
NCIt43 C4438

Summaries for Liver Angiosarcoma

About this section
Disease Ontology:11 An angiosarcoma and sarcoma of liver and hemangioma of intra-abdominal structure and ca liver - primary that is located in the liver.

MalaCards based summary: Liver Angiosarcoma, also known as angiosarcoma of liver, is related to hepatocellular carcinoma and rubella panencephalitis. An important gene associated with Liver Angiosarcoma is KRAS (KRAS Proto-Oncogene, GTPase), and among its related pathways are CD209 (DC-SIGN) signaling and Long-term depression. Affiliated tissues include the liver, liver and endothelial, and related mouse phenotypes are craniofacial and pigmentation.

Related Diseases for Liver Angiosarcoma

About this section

Diseases related to Liver Angiosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 202)
idRelated DiseaseScoreTop Affiliating Genes
1hepatocellular carcinoma27.9CDK4, CDKN2A, CYP2E1, KRT19, TP53
2rubella panencephalitis10.7KRT19, VIM
3pulmonary venoocclusive disease10.7KRAS, VIM
4familial papillary or follicular thyroid carcinoma10.7KRT19, VIM
5acute sanguinous otitis media10.7KRAS, KRT19
6pterygium colli mental retardation digital anomalies10.7KRAS, NRAS
7brachydactyly, type e210.7KRAS, NRAS
8rad51c-related fanconi anemia10.7KRAS, NRAS
9oligoastrocytoma10.6KRT19, VIM
102q33.1 microdeletion syndrome10.6ENO2, VIM
11malignant hyperthermia susceptibility10.6KRAS, TP53
12sm-ahnmd10.5TP53, VIM
13rectum mucinous adenocarcinoma10.5KRAS, TP53
14kidney sarcoma10.5TP53, VIM
15eccrine papillary adenoma10.5TP53, VIM
16exstrophy-epispadias complex10.5ENO2, VIM
17skin lipoma10.5CDK4, VIM
18skin glomangioma10.5TP53, VIM
19mediastinum teratoma10.5KRAS, TP53
20classic pulmonary blastoma10.5KRAS, TP53
21congenital myasthenic syndrome10.5KRT19, TP53
22vagina sarcoma10.5HRAS, KRAS
23glomerulosclerosis10.4HRAS, KRAS
24gonococcal spondylitis10.4HRAS, KRAS
25myxosarcoma10.4HRAS, KRAS
26lateral medullary syndrome10.4ENO2, NRAS
27seminal vesicle chronic gonorrhea10.4HRAS, KRAS
28red-green color blindness10.4CYP2E1, TP53
29chromosome 7p duplication10.4CDK4, TP53
30angora hair nevus10.4ENO2, VIM
31bladder clear cell adenocarcinoma10.4ENO2, KRT19
32trachea adenoid cystic carcinoma10.4HRAS, KRAS
33vulvar alveolar soft part sarcoma10.4HRAS, VIM
34breast papillary carcinoma10.4HRAS, KRAS
35melanocytic nevus syndrome, congenital, somatic10.4HRAS, NRAS
36bile duct disease10.4TP53, VWF
37demyelinating polyneuropathy10.4HRAS, NRAS
38uterine ligament serous adenocarcinoma10.4HRAS, KRAS
39hypersensitivity reaction type ii disease10.4ENO2, TP53
40mixed endometrial stromal and smooth muscle tumor10.3ENO2, TP53
41appendix mucinous cystadenocarcinoma10.3HRAS, KRAS
42sublingual gland adenoid cystic carcinoma10.3HRAS, NRAS
43coloboma of macula and skeletal anomalies10.3HRAS, NRAS
44tabes dorsalis10.3HRAS, KRAS
45angiosarcoma10.3
46asthenopia10.3CYP2E1, TP53
47pediatric testicular germ cell tumor10.3ENO2, KRAS
48kidney cortex necrosis10.3ENO2, TP53
49nasal cavity adenocarcinoma10.3KRAS, KRT19, TP53
50vascular hemostatic disease10.3HRAS, VIM

Graphical network of the top 20 diseases related to Liver Angiosarcoma:



Diseases related to liver angiosarcoma

Symptoms for Liver Angiosarcoma

About this section

Drugs & Therapeutics for Liver Angiosarcoma

About this section

Drugs for Liver Angiosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DoxilApproved June 1999Phase 3, Phase 1167631703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
2
DoxorubicinPhase 3, Phase 1167623214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5
3
MechlorethaminePhase 336351-75-24033
Synonyms:
.Beta.,.beta.'-Dichlorodiethyl-N-methylamine
1, 5-Dichloro-3-methyl-3-azapentane hydrochloride
126-85-2 (N-oxide)
2,2'-Dichloro-N-me
2,2'-Dichloro-N-methyldiethylamine
2,2'-Dichlorodiethyl-methylamine
2,2'-dichloro-N-methyldiethylamine
2-Chloro-N-(2-chloroethyl)-N-methylethanamine
302-70-5 (N-oxide, hydrochloride)
51-75-2
55-86-7 (HYDROCHLORIDE)
AC1L1H9H
Antimit
BRN 0605323
BSPBio_001947
Bis(2-chloroethyl)methylamine
Bis(beta-chloroethyl) methylamine
Bis(beta-chloroethyl)methylamine
C07115
C5H11Cl2N
CCRIS 447
CHEBI:28925
CHEMBL427
CID4033
Carolysine
Caryolysin
Caryolysine
Chloramine (the nitrogen mustard)
Chlorethazine
Chlormethine
Chlormethine (INN)
Chlormethine [INN:BAN]
Chlormethinum [INN-Latin]
Cloramin
Clormetina
Clormetina [INN-Spanish]
D07671
DB00888
Di(2-chloroethyl)methylamine
Dichlor amine
Dichloren
DivK1c_000759
EINECS 200-120-5
ENT-25294
Embechine
Embichin
HMS1920J15
HMS2091B04
HMS502F21
HN-2
HN2
HSDB 5083
I14-8708
IBS-L0033631
IDI1_000759
KBio1_000759
KBio2_001369
KBio2_003937
KBio2_006505
KBio3_001447
 
KBioGR_001448
KBioSS_001369
LS-7559
MBA
Me chloroethamine
Mebichloramine
Mechlorethamine
Mechlorethanamine
Mechloroethamine
Mecloretamina
Mecloretamina [Italian]
Methylbis(2-chloroethyl)amine
Methylbis(beta-chloroethyl)amine
Methyldi(2-chloroethyl)amine
Mitoxine (*Hydrochloride*)
MolPort-001-785-592
Mustargen
Mustine
Mustine note
Mutagen
N,N-Bis(2-chloroethyl)-N-methylamine
N,N-Bis(2-chloroethyl)methylamine
N,N-Di(chloroethyl)methylamine
N-Lost
N-Methyl lost
N-Methyl-2,2'-dichlorodiethylamine
N-Methyl-bis(2-chloroethyl)amine
N-Methyl-bis(beta-chloroethyl)amine
N-Methyl-bis-chloraethylamin
N-Methyl-bis-chloraethylamin [German]
N-Methyl-lost
N-Methyl-lost [German]
N-methyl-bis(2-chloroethyl)amine
NCGC00091835-02
NCGC00091835-03
NCGC00091835-04
NCGC00091835-05
NCI60_041682
NINDS_000759
NSC762
Nitol (*Hydrochloride*)
Nitrogen mustard
Nitrogen mustard (HN-2)
Nitrogranulogen
SPBio_000496
SPECTRUM1500375
Spectrum2_000448
Spectrum3_000484
Spectrum4_000924
Spectrum5_001702
Spectrum_000889
Stickstofflost (*Hydrochloride*)
Stickstofflost (ebewe)
T 1024
T-1024
TL 146
UNII-50D9XSG0VR
beta,Beta'-dichlorodiethyl-N-methylamine
beta,beta'-Dichlorodiethyl-N-methylamine
mechlorethamine
thyldiethylamine
╬▓,╬▓'-dichlorodiethyl-N-methylamine
4Isophosphamide mustardPhase 3386
5
IfosfamidePhase 33863778-73-23690
Synonyms:
(+-)-Ifosfamid
(+-)-Ifosphamide
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
(D,L)-Ifosfamide
(R,S)-Ifosphamide
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
3,} 2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
36341-88-5
3778-73-2
84711-20-6
A 4942
AB00513932
AC-2113
AC1L1GHW
ASTA Z 4942
Ambap3778-73-2
Asta Z 4942
BPBio1_000865
BRN 0611835
BSPBio_000785
C07047
CAS-3778-73-2
CCRIS 352
CHEBI:5864
CHEMBL1024
CID3690
Cyfos
D00343
D007069
DB01181
EINECS 223-237-3
HMS1570H07
HMS2090M12
HMS2093N07
HSDB 7023
Holoxan
Holoxan 1000
I-Phosphamide
I06-0494
IFEX (TN)
Ifex
Ifosfamid
Ifosfamida
Ifosfamida [INN-Spanish]
Ifosfamide (JAN/USP/INN)
 
Ifosfamide Sterile
Ifosfamide [USAN:INN:BAN:JAN]
Ifosfamidum
Ifosfamidum [INN-Latin]
Ifosphamide
Ifsofamide
Iphosphamid
Iphosphamid(e)
Iphosphamide
Iso Endoxan
Iso-Endoxan
Isoendoxan
Isofosfamide
Isophosphamide
Isosfamide
LS-102
LS-99799
MJF 9325
MJF-9325
MLS002154021
Mitoxana
Mitoxana, Ifex, Ifosfamide
MolPort-003-666-704
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine
NCGC00016639-01
NCGC00179435-01
NCI-C01638
NCI60_000233
NPFAPI-04
NSC 109,724
NSC 109724
NSC-109,724
NSC-109724
NSC109,724
NSC109724
Naxamide
Prestwick0_000833
Prestwick1_000833
Prestwick2_000833
Prestwick3_000833
S1302_Selleck
SMR001233348
SPBio_002706
STL058690
UNII-UM20QQM95Y
WLN: T6NPOTJ AM2G BO B2G
Z 4942
Z-4942
Z4942
ifosfamide
isosfamide
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,
6Alkylating AgentsPhase 34573
7
GemcitabinePhase 2192895058-81-460750
Synonyms:
103882-84-4
122111-03-9
2',2'-DiF-dC
2',2'-Difluoro-2'-deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-.beta.-D-2',2'-difluorocytidine
2'-Deoxy-2',2'-difluorocytidine
4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one
4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
95058-81-4
AB1004842
AC1L1TUQ
C07650
CCRIS 8984
CHEBI:175901
CHEMBL888
CID60750
Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine
D02368
DB00441
DDFC
DFDC
DFdC
DFdCyd
Folfugem
GEO
Gamcitabine
GemLip
Gemcel
 
Gemcin
Gemcitabin
Gemcitabina
Gemcitabina [INN-Spanish]
Gemcitabine
Gemcitabine (USAN/INN)
Gemcitabine HCl
Gemcitabine hydrochloride
Gemcitabine stereoisomer
Gemcitabinum
Gemcitabinum [INN-Latin]
Gemtro
Gemzar
Gemzar (hydrochloride)
HMS2089P10
HSDB 7567
Inno-D07001
LS-59139
LY 188011
LY-188011
LY188011
NCGC00168784-01
NChemBio.2007.10-comp25
NSC 613327
NSC613327
TL8005979
UNII-B76N6SBZ8R
ZINC18279854
Zefei
gemcitabine
nchembio.573-comp7
nchembio.90-comp2
8
RomidepsinPhase 284128517-07-75352062
Synonyms:
(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo(8.7.6)tricos-16-ene-3,6,9,19,22-pentone
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
128517-07-7
AC1NS1N3
Antibiotic FR 901228
C087123
C24H36N4O6S2
CHEBI:61080
CHEMBL343448
CID5352062
Chromadax
Chromadax (TN)
Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (3?5)-disulfide"
D06637
FK 228
FK-228
 
FK-901228
FK228
FR 901228
FR-901228
FR901228
HDInhib_000006
Istodax
L-Valine, N-((3S,4E)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide
LS-161318
NSC 630176
NSC-630176
NSC630176
Probes1_000153
Probes2_000337
Romidepsin
Romidepsin (USAN)
chromodax
istodax
nchembio.313-comp2

Interventional clinical trials:

idNameStatusNCT IDPhase
1Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue SarcomaActive, not recruitingNCT00346164Phase 3
2Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaCompletedNCT01154452Phase 1, Phase 2
3Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue SarcomaRecruitingNCT01532687Phase 2
4Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue SarcomaActive, not recruitingNCT00112463Phase 2
5Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaCompletedNCT00720174Phase 1
6Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue SarcomasCompletedNCT01567046
7Identification, Molecular Epidemiology Angiosarcoma of the Liver FranceActive, not recruitingNCT01786889

Search NIH Clinical Center for Liver Angiosarcoma

Genetic Tests for Liver Angiosarcoma

About this section

Anatomical Context for Liver Angiosarcoma

About this section

MalaCards organs/tissues related to Liver Angiosarcoma:

34
Liver, Endothelial

FMA organs/tissues related to Liver Angiosarcoma:

17
The liver

Animal Models for Liver Angiosarcoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Liver Angiosarcoma:

39 (show all 21)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053828.9ENO2, HRAS, KRAS, NRAS, TP53
2MP:00011868.9CDK4, CDKN2A, KRAS, NRAS, TP53
3MP:00053708.6CDK4, CDKN2A, CYP2E1, KRAS, NRAS, TP53
4MP:00053888.2CDKN2A, ENO2, HRAS, KRAS, TP53, VIM
5MP:00053918.1CDK4, CDKN2A, KRAS, NRAS, TP53, VIM
6MP:00053807.6CDK4, CDKN2A, KRAS, KRT19, NRAS, TP53
7MP:00107717.5CDK4, CDKN2A, HRAS, KRAS, KRT19, NRAS
8MP:00030127.5CDKN2A, HRAS, KRAS, KRT19, NRAS, TP53
9MP:00053817.5CDK4, CDKN2A, KRAS, KRT19, NRAS, TP53
10MP:00053797.1CDK4, CDKN2A, HRAS, KRAS, KRT19, NRAS
11MP:00020067.1CDK4, CDKN2A, CYP2E1, HRAS, KRAS, KRT19
12MP:00053766.8CDK4, CDKN2A, CYP2E1, HRAS, KRAS, NRAS
13MP:00053846.7CDK4, CDKN2A, ENO2, KRAS, KRT19, NRAS
14MP:00053786.4CDK4, CDKN2A, ENO2, HRAS, KRAS, KRT19
15MP:00053866.4CDK4, CDKN2A, CYP2E1, ENO2, HRAS, KRAS
16MP:00036316.3CDK4, CDKN2A, ENO2, HRAS, KRAS, KRT19
17MP:00107686.2CDK4, CDKN2A, CYP2E1, HRAS, KRAS, KRT19
18MP:00053856.1CDK4, CDKN2A, CYP2E1, HRAS, KRAS, KRT19

Publications for Liver Angiosarcoma

About this section

Articles related to Liver Angiosarcoma:

(show all 17)
idTitleAuthorsYear
1
Sequential development of hepatocellular carcinoma and liver angiosarcoma in a vinyl chloride-exposed worker. (27544804)
2016
2
Liver angiosarcoma, a rare liver malignancy, presented with intraabdominal bleeding due to rupture--a case report. (22280556)
2012
3
Widening spectrum of liver angiosarcoma in children. (21832953)
2011
4
Mutation analysis of K-ras-2 in liver angiosarcoma and adjacent nonneoplastic liver tissue from patients occupationally exposed to vinyl chloride. (12211074)
2002
5
Establishment and characterization of a spontaneously immortalized myofibroblast cell line derived from a human liver angiosarcoma. (10952247)
2000
6
Liver angiosarcoma and hemangiopericytoma after occupational exposure to vinyl chloride monomer. (10964802)
2000
7
Diffuse liver angiosarcoma and cerebral cavernous angiomas in a young patient. (10692780)
1999
8
Two new cases of liver angiosarcoma: history and perspectives of liver angiosarcoma among plastic industry workers. (9284534)
1997
9
Vinylchloride monomer exposure by the plastic industry workers basic condition for liver angiosarcoma appearance. (9277092)
1996
10
Activation of Ki-ras gene by point mutation in human liver angiosarcoma associated with vinyl chloride exposure. (1793483)
1991
11
Invasive character of malignant endothelial cells in vinyl-chloride-induced liver angiosarcoma. (2381457)
1990
12
Massive bleeding after fine needle aspiration of liver angiosarcoma. (2298353)
1990
13
Liver angiosarcoma in a vinyl chloride polymerization plant worker. Report of the seventh Italian case. (3173221)
1988
14
Iatrogenic disease. Lipoid pneumonia and liver angiosarcoma. (3714604)
1986
15
Two cases of liver angiosarcoma among polyvinyl chloride (PVC) extruders of an Italian factory producing PVC bags and other containers. (6539068)
1984
16
Log normal distribution of the incubation period of liver angiosarcoma in vinyl chloride polymerization workers. (569691)
1979
17
Persistence of DNA damage during development of liver angiosarcoma in rats fed dimethylnitrosamine. (570883)
1979

Variations for Liver Angiosarcoma

About this section

Expression for genes affiliated with Liver Angiosarcoma

About this section
Search GEO for disease gene expression data for Liver Angiosarcoma.

Pathways for genes affiliated with Liver Angiosarcoma

About this section

Pathways related to Liver Angiosarcoma according to GeneCards Suite gene sharing:

(show top 50)    (show all 74)
idSuper pathwaysScoreTop Affiliating Genes
19.3HRAS, KRAS, NRAS
29.3HRAS, KRAS, NRAS
39.3HRAS, KRAS, NRAS
49.3HRAS, KRAS, NRAS
59.3HRAS, KRAS, NRAS
69.3HRAS, KRAS, NRAS
7
Show member pathways
9.3HRAS, KRAS, NRAS
8
Show member pathways
9.3HRAS, KRAS, NRAS
99.3HRAS, KRAS, NRAS
10
Show member pathways
9.3HRAS, KRAS, NRAS
11
Show member pathways
9.3HRAS, KRAS, NRAS
12
Show member pathways
9.3HRAS, KRAS, NRAS
139.3HRAS, KRAS, NRAS
14
Show member pathways
9.3HRAS, KRAS, NRAS
159.0CDK4, CDKN2A, TP53
169.0HRAS, KRAS, NRAS, VWF
178.9CDKN2A, HRAS, TP53
188.9HRAS, KRAS, NRAS, TP53
19
Show member pathways
8.9HRAS, KRAS, NRAS, TP53
20
Show member pathways
8.9HRAS, KRAS, NRAS, TP53
21
Show member pathways
8.9HRAS, KRAS, NRAS, TP53
22
Show member pathways
8.9HRAS, KRAS, NRAS, TP53
23
Show member pathways
8.9HRAS, KRAS, NRAS, TP53
24
Show member pathways
8.9HRAS, KRAS, NRAS, TP53
25
Show member pathways
8.9HRAS, KRAS, NRAS, TP53
26
Show member pathways
8.9HRAS, KRAS, NRAS, TP53
27
Show member pathways
8.9HRAS, KRAS, NRAS, TP53
288.9HRAS, KRAS, NRAS, TP53
298.9HRAS, KRAS, NRAS, TP53
308.9HRAS, KRAS, NRAS, TP53
318.9HRAS, KRAS, NRAS, TP53
328.9HRAS, KRAS, NRAS, TP53
338.9HRAS, KRAS, NRAS, TP53
348.9CDK4, HRAS, KRAS, NRAS
35
Show member pathways
8.9CDK4, HRAS, KRAS, NRAS
368.9CDK4, HRAS, KRAS, NRAS
37
Show member pathways
8.7CDK4, CDKN2A, KRAS, TP53
388.7CDK4, CDKN2A, TP53, VIM
39
Show member pathways
8.6CDK4, HRAS, KRAS, NRAS, VIM
40
Show member pathways
8.5CDK4, HRAS, KRAS, NRAS, TP53
41
Show member pathways
8.3CDKN2A, HRAS, KRAS, NRAS, TP53
428.1CDK4, HRAS, KRAS, NRAS, TP53, VWF
438.0CDKN2A, HRAS, KRAS, NRAS, TP53, VIM
44
Show member pathways
7.8CDK4, CDKN2A, HRAS, KRAS, NRAS, TP53
457.8CDK4, CDKN2A, HRAS, KRAS, NRAS, TP53
467.8CDK4, CDKN2A, HRAS, KRAS, NRAS, TP53
477.8CDK4, CDKN2A, HRAS, KRAS, NRAS, TP53
487.8CDK4, CDKN2A, HRAS, KRAS, NRAS, TP53
497.8CDK4, CDKN2A, HRAS, KRAS, NRAS, TP53
50
Show member pathways
7.8CDK4, CDKN2A, HRAS, KRAS, NRAS, TP53

GO Terms for genes affiliated with Liver Angiosarcoma

About this section

Biological processes related to Liver Angiosarcoma according to GeneCards Suite gene sharing:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of cellular senescenceGO:200077410.1CDKN2A, KRAS
2replicative senescenceGO:00903999.9CDKN2A, TP53
3cellular senescenceGO:00903989.8CDKN2A, HRAS
4Fc-epsilon receptor signaling pathwayGO:00380959.8HRAS, KRAS, NRAS
5stimulatory C-type lectin receptor signaling pathwayGO:00022239.8HRAS, KRAS, NRAS
6ERBB2 signaling pathwayGO:00381289.7HRAS, KRAS, NRAS
7epidermal growth factor receptor signaling pathwayGO:00071739.7HRAS, KRAS, NRAS
8leukocyte migrationGO:00509009.4HRAS, KRAS, NRAS
9regulation of long-term neuronal synaptic plasticityGO:00481699.4HRAS, KRAS
10axon guidanceGO:00074119.3HRAS, KRAS, NRAS
11cell cycle arrestGO:00070509.3CDKN2A, HRAS, TP53
12positive regulation of gene expressionGO:00106289.2HRAS, KRAS, TP53, VIM
13Ras protein signal transductionGO:00072658.3CDKN2A, HRAS, KRAS, NRAS, TP53

Molecular functions related to Liver Angiosarcoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein complex bindingGO:00324038.6CDK4, KRAS, KRT19, NRAS

Sources for Liver Angiosarcoma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet